Latest News of AMGN
The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period
By Yahoo! Finance |
5 days ago
Amgen Inc. (NASDAQ: AMGN) shareholders saw a 13% drop in share price last week, yet the company's three-year returns were strong at 38%, surpassing the market index. Despite a decline in earnings per ...
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?
By Yahoo! Finance |
2 weeks ago
The pharmaceutical industry is witnessing a shift towards weight-loss drugs like Ozempic and Wegovy, showing potential in treating addiction and conditions like Alzheimer's. Despite challenges like fu...
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
By Yahoo! Finance |
2 weeks ago
Amgen Inc's recent 10-Q filing reveals a strong financial performance with increased product sales driven by volume growth and strategic acquisitions. The company's resilience in navigating challenges...
-
Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ...
By Yahoo! Finance | 3 weeks agoThe CEO and executives of a pharmaceutical company discuss plans for a Phase III trial of MariTide for obesity and diabetes. They are optimistic about MariTide's potential and are actively planning a ...
-
Amgen (AMGN) Q3 2024 Earnings Call Transcript
By Yahoo! Finance | 3 weeks agoThe Amgen Q3 2024 Earnings Call discussed the company's performance, pipeline updates, and growth strategies across core therapeutic areas. Highlights included strong revenue growth, progress in rare ...
-
Amgen Inc. (AMGN): A Buzzing AI Health Stock to Add to Your Portfolio
By Yahoo! Finance | 1 month agoThe article discusses the impact of AI in healthcare, with a focus on Amgen Inc. as one of the top buzzing AI health stocks. AI is projected to drive transformative growth in healthcare, enhancing dia...
-
Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication
By Yahoo! Finance | 1 month agoPGIM Jennison Health Sciences Fund's Q2 2024 investor letter discussed stock performance, highlighting Amgen Inc. (NASDAQ:AMGN). The fund noted Amgen's one-month return and market capitalization. They...
-
Amgen Inc. (AMGN): Hedge Fund Interest and Strong Pipeline Support Moderate Buy Rating
By Yahoo! Finance | 1 month agoA recent article ranks Amgen Inc. (NASDAQ:AMGN) as the 9th best healthcare stock to buy according to hedge funds. The healthcare sector is growing, with increasing healthcare spending and advancements...
-
Amgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts
By Yahoo! Finance | 1 month agoThe article discusses Amgen Inc. as one of the undervalued wide moat stocks, highlighting its strong portfolio and growth potential. Analysts believe in its revenue growth, with projections for 2024....
-
Amgen (NASDAQ:AMGN) shareholders have earned a 15% CAGR over the last five years
By Yahoo! Finance | 1 month agoInvesting for the long term aims to generate profit, with Amgen Inc. seeing a 73% share price increase in 5 years. However, EPS declined by 14% annually. Despite revenue growth, it's important to asse...
-
Amgen Inc. (AMGN): A Bull Case Theory
By Yahoo! Finance | 2 months agoAmgen Inc. is analyzed in a bullish thesis by Magnus Ofstad, highlighting its diverse drug portfolio and growth potential, particularly with the promising MariTide obesity treatment. Despite debt conc...
-
Can Amgen Inc.'s (NASDAQ:AMGN) ROE Continue To Surpass The Industry Average?
By Yahoo! Finance | 2 months agoReturn on Equity (ROE) measures a company's profitability relative to shareholders' equity. Amgen Inc. has an ROE of 53%, indicating efficient capital utilization. A high ROE can be influenced by debt...
-
Amgen Inc. (AMGN): Why Do Hedge Funds Recommend This Biotech Stock?
By Yahoo! Finance | 2 months agoInsider Monkey compiled a list of top biotech stocks favored by hedge funds, including Amgen Inc. (NASDAQ:AMGN). The biotech industry is projected to grow significantly, driven by innovations like AI-...
-
Are Hedge Funds Bullish on Amgen Inc. (AMGN) Now?
By Yahoo! Finance | 3 months agoA list of top GLP-1 and weight loss stocks includes Amgen Inc. (NASDAQ: AMGN), a key player in the market. The global obesity drug market is projected to reach $105 billion by 2030, with semaglutide l...
-
An Intrinsic Calculation For Amgen Inc. (NASDAQ:AMGN) Suggests It's 47% Undervalued
By Yahoo! Finance | 3 months agoAn analyst's price target for AMGN is $318, 48% below its fair value estimate. Using a Discounted Cash Flow model, the intrinsic value of Amgen Inc. is calculated at $329 billion, indicating the stock...